Hysterectomy, endometrial ablation and Mirena® for heavy menstrual bleeding: a systematic review of clinical effectiveness and cost-effectiveness analysis.

OBJECTIVE: The aim of this project was to determine the clinical effectiveness and cost-effectiveness of hysterectomy, first- and second-generation endometrial ablation (EA), and Mirena® (Bayer Healthcare Pharmaceuticals, Pittsburgh, PA, USA) for the treatment of heavy menstrual bleeding. DESIGN: In...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Health Technol Assess
Autores principales: Bhattacharya, S, Middleton, L J, Tsourapas, A, Lee, A J, Champaneria, R, Daniels, J P, Roberts, T, Hilken, N H, Barton, P, Gray, R, Khan, K S, Chien, P, O'Donovan, P, Cooper, K G, Abbott, J, Barrington, J, Bongers, M Y, Brun, J-L, Busfield, R, Clark, T J, Cooper, J, Corson, S L, Dickersin, K, Dwyer, N, Gannon, M, Hawe, J, Hurskainen, R, Meyer, W R, O'Connor, H, Pinion, S, Sambrook, A M, Tam, W H, van Zon-Rabelink, I A A, Zupi, E
Formato: Artigo
Lenguaje:Inglês
Publicado: NIHR Journals Library 2011
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4781434/
https://ncbi.nlm.nih.gov/pubmed/21535970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta15190
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares